fraxinellone has been researched along with folic acid in 1 studies
| Studies (fraxinellone) | Trials (fraxinellone) | Recent Studies (post-2010) (fraxinellone) | Studies (folic acid) | Trials (folic acid) | Recent Studies (post-2010) (folic acid) |
|---|---|---|---|---|---|
| 46 | 0 | 34 | 30,001 | 1,945 | 10,195 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Kong, L; Sun, X; Tan, Y; Wang, S; Wang, T; Wu, X; Xu, Q; Xu, Y; Ye, J; Yuan, M; Zheng, B | 1 |
1 other study(ies) available for fraxinellone and folic acid
| Article | Year |
|---|---|
Fraxinellone alleviates kidney fibrosis by inhibiting CUG-binding protein 1-mediated fibroblast activation.
Topics: Animals; Benzofurans; CELF1 Protein; Cell Line; Disease Models, Animal; Fibroblasts; Fibrosis; Folic Acid; JNK Mitogen-Activated Protein Kinases; Kidney; Kidney Diseases; Male; Mice, Inbred C57BL; p38 Mitogen-Activated Protein Kinases; Rats; Transforming Growth Factor beta1 | 2021 |